Buscar
Mostrando ítems 41-50 de 220
Laparoscopic repair of vesicovaginal fistula
(Mary Ann Liebert, Inc., 2014)
Laparoscopic sacral colpopexy
(Mary Ann Liebert, Inc., 2014)
Linear epitopes of Paracoccidioides brasiliensis and Other Fungal Agents of Human Systemic Mycoses As vaccine Candidates
(Frontiers Media Sa, 2017)
Dimorphic fungi are agents of systemic mycoses associated with significant morbidity and frequent lethality in the Americas. Among the pathogenic species are Paracoccidioides brasiliensis and Paracoccidioides lutzii, which ...
From yeast killer toxins to antibiobodies and beyond
(Wiley-Blackwell, 2008-11-01)
Antibiobodies are paradigmatic of yeast killer toxin (KT)-like antibodies (KAbs) mimicking the antimicrobial activity of KTs in the frame of the yeast killer phenomenon. Polyclonal, monoclonal and recombinant anti-idiotypic ...
Treatment options for paracoccidioidomycosis and new strategies investigated
(Expert Reviews, 2008-04-01)
Paracoccidioidomycosis is the most prevalent systemic endemic mycosis in South America with most reported cases in Brazil. It is a major cause of disability and death among young adult rural workers during their most ...
In Vitro and in Vivo Trypanocidal Effects of the Cyclopalladated Compound 7a, a Drug Candidate for Treatment of Chagas' Disease
(Amer Soc Microbiology, 2010-08-01)
Chagas' disease, a neglected tropical infection, affects about 18 million people, and 100 million are at risk. the only drug available, benznidazole, is effective in the acute form and in the early chronic form, but its ...
New advances in the development of a vaccine against paracoccidioidomycosis
(Frontiers Research Foundation, 2012-01-01)
Paracoccidioidomycosis (PCM) is an endemic Latin American mycosis caused by Paracoccidioides brasiliensis and also by the recently described P. lutzii. the systemic mycosis is the 10th leading cause of death due to infectious ...
Paracoccidioidomycosis vaccine
(Landes Bioscience, 2012-10-01)
Paracoccidioidomycosis is a granulomatous pulmonary infection that is generally controlled by chemotherapy. the efficacy of treatment, however, is limited by the status of the host immune response. the inhibition of a Th-2 ...